| Kristen Brandon, MD | |
|
2710 S Rife Medical Ln, Rogers, AR 72758-1452 | |
| (479) 636-0200 | |
| (479) 986-3448 |
| Full Name | Kristen Brandon |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 2710 S Rife Medical Ln, Rogers, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942434394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | E-8071 (Arkansas) | Secondary |
| 207R00000X | Internal Medicine | E-8071 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578593067 PECOS PAC ID: 0648177949 Enrollment ID: O20031215000977 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Entity Name | Mercy Hospital Berryville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306326 PECOS PAC ID: 9032022769 Enrollment ID: O20040505000763 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932118890 PECOS PAC ID: 7911802079 Enrollment ID: O20040726000650 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Entity Name | Mercy Hospital Berryville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1457306326 PECOS PAC ID: 9032022769 Enrollment ID: O20061104000216 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Entity Name | Mercy Health Northwest Arkansas Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699076737 PECOS PAC ID: 0648177873 Enrollment ID: O20110330000454 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Brandon, MD Po Box 776084, Chicago, IL 60677-6084 Ph: (314) 364-4200 | Kristen Brandon, MD 2710 S Rife Medical Ln, Rogers, AR 72758-1452 Ph: (479) 636-0200 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
New information published in the Journal of Applied Biobehavioral Research explores University students' motivations for using or not using cannabis and found various factors that might encourage use.
› Verified 6 days ago
Dr. Anthony Dolomisiewicz, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1002 S 52nd St, Rogers, AR 72758 Phone: 479-338-3722 Fax: 479-338-3724 | |
William G Swindell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1002 S 52nd Street, Rogers, AR 72758 Phone: 479-338-3750 Fax: 479-338-3799 | |
Dr. Daniel S Bradford, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 808 S 52nd St, Rogers, AR 72758 Phone: 479-936-9900 Fax: 479-587-1366 | |
Dr. Walton Cheng Toy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1002 S 52nd Street, Rogers, AR 72758 Phone: 479-338-3720 Fax: 479-338-3749 | |
Dr. Ruben Tejada, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5212 Village Pkwy, Suite 9, Rogers, AR 72758 Phone: 479-876-8460 Fax: 479-876-8470 | |
Dr. James Parks Tullis, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1002 S 52nd St, Rogers, AR 72758 Phone: 479-338-3750 Fax: 479-338-3799 | |
Kevin Bradley Meredith, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln Ste 200, Rogers, AR 72758 Phone: 479-338-3080 Fax: 479-338-3089 |